Clinical Trial Update: Vascular Healing After Deployment of Titanium-nitride-oxide-coated OPTIMAX™ Stent and PROMUS-ELEMENT™ Everolimus-Eluting Stent [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on vascular healing after deployment of two stents—the titanium-nitride-oxide-coated OPTIMAX stent and the PROMUS Element everolim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• OPTIMAX Titanium-nitride-oxide-coated Stent (TiNO-coated stent)
• PROMUS Element Everolimus-eluting Stent (everolimus-eluting stent)

Snippet

Sponsor: The Hospital District of Satakunta | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED